CTLA4 and neoplasm: To our knowledge, this is the largest published study analyzing prevalence and prognostic importance of CTLA-4 expression in NSCLC, and the first to assess both tumor and stromal cells of NSCLC PTs as well as matched LN+ [23–26, 34–36].